Factors that May Predict the Likelihood of Generic Drug Marketing Applications

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - A podcast by DrugPatentWatch

Categories:

The FDA conducted a study to identify factors that may predict the likelihood of generic drug marketing applications. The study focused on abbreviated new drug applications (ANDAs) submitted to the FDA, relying on existing reference (approved) drug products. The researchers analyzed data for 400 brand-name drugs, of which 140 were new chemical entities (NCEs) and […] Source